Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI/PET monitoring of macrophage infiltration in multiple sclerosis patients treated with Tysabri
2007-006205-25Phase 4Active
- Sponsor
- Strasbourg University Hospital
- Start
- Aug 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of natalizumab in multiple sclerosis (MS), sponsored by Strasbourg University Hospital. Primary endpoints: Quantitative analysis of contrast enhancement intensity and Quantitative analysis of the number of contrast-enhancing lesions. Started Aug 2008; status: active.
02
Drugs
natalizumab
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2007-006205-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006205-25.